Literature DB >> 29263746

Multiple fractures and impaired bone metabolism in Wolfram syndrome: a case report.

Antonino Catalano1, Federica Bellone1, Giuseppe Cicala2, Annalisa Giandalia1, Nunziata Morabito1, Domenico Cucinotta1, Giuseppina Tiziana Russo1.   

Abstract

Wolfram Syndrome (WS) is a rare and lethal disease characterized by optic atrophy, diabetes mellitus, diabetes insipidus, and hearing loss. To date, osteoporotic related fractures have not been reported in affected patients. Here, we describe the case of a man affected by WS complicated by several bone fragility fractures. A 50-year-old Caucasian man was hospitalized because of tibia and fibula fractures. His clinical features included diabetes mellitus, diabetes insipidus, optic atrophy and deafness that were consistent with an unrecognized WS diagnosis, which was confirmed by the identification of a specific mutation in gene WFS1 encoding wolframin. Bone mineral density by phalangeal quantitative ultrasound demonstrated severe osteoporosis, with high serum levels of surrogate markers of bone turn-over. Previously unidentified rib fractures were also detected. To the best of our knowledge, this is the first report of osteoporotic related fractures in a patient affected by WS. Although no effective treatments are currently available to delay the progression of the disease, this case report suggests to evaluate fracture risk in the diagnostic work-up of WS.

Entities:  

Keywords:  Wolfram syndrome; bone; diabetes; fractures; osteoporosis

Year:  2017        PMID: 29263746      PMCID: PMC5726222          DOI: 10.11138/ccmbm/2017.14.2.254

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  27 in total

Review 1.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

Review 2.  Diabetes and bone: biological and environmental factors.

Authors:  Prisco Piscitelli; Cosimo Neglia; Antonella Vigilanza; Annamaria Colao
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

3.  Altered PGE2 production by glomeruli and papilla of rats with hereditary diabetes insipidus.

Authors:  L Bankir; M M Trinh Trang Tan; M P Nivez; J Sraer; R Ardaillou
Journal:  Prostaglandins       Date:  1980-08

4.  Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization.

Authors:  W G Goodman; M T Hori
Journal:  Diabetes       Date:  1984-09       Impact factor: 9.461

5.  Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina.

Authors:  Antonino Catalano; Nancy Morabito; Giorgio Basile; Sergio Fusco; Graziella Castagna; Francesca Reitano; Raffaella Ciano Albanese; Antonino Lasco
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

Review 6.  Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes - mechanisms and potentials for treatment.

Authors:  A Giaccari; G Sorice; G Muscogiuri
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-05-09       Impact factor: 4.222

Review 7.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

8.  Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment.

Authors:  P K Dixit; R A Ekstrom
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

9.  Wolfram syndrome: new mutations, different phenotype.

Authors:  Concetta Aloi; Alessandro Salina; Lorenzo Pasquali; Francesca Lugani; Katia Perri; Chiara Russo; Ramona Tallone; Gian Marco Ghiggeri; Renata Lorini; Giuseppe d'Annunzio
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

Review 10.  Wolfram Syndrome: Diagnosis, Management, and Treatment.

Authors:  Fumihiko Urano
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

View more
  1 in total

1.  Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors.

Authors:  A Catalano; A Gaudio; R M Agostino; N Morabito; F Bellone; A Lasco
Journal:  J Endocrinol Invest       Date:  2019-05-24       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.